University Pointe Surgical Hospital Earns Joint Commission Accreditation
WEST CHESTERFollowing an unannounced, comprehensive on-site evaluation, University Pointe Surgical Hospital was awarded the Joint Commissions Gold Seal of Approval accreditation.
The accreditation process evaluates quality and safety within health care organizations, and identifies opportunities for improvement for organizations to continuously provide safe, high-quality care, treatment and services.
The Joint Commission found the hospital compliant at all levels within the Hospital Accreditation Program, and granted accreditation for the next 39 months for all services surveyed.
University Pointe Surgical Hospital is a joint partnership between UC Physicians and the Health Alliance of Greater Cincinnati. The eight-bed hospital specializes in inpatient and outpatient surgeries, including endoscopies, biopsies, orthopedic procedures, gynecologic surgeries, cosmetic surgeries, bariatric procedures, pain management procedures, orthopedic surgeries and ear, nose and throat procedures. The hospital also offers diagnostic imaging, including MRI, CT, ultrasound and mammography.
University Pointes accreditation highlights the fact that we are committed to continuously meeting rigorous national standards of excellence, said Carol King, executive director of University Point Surgical Hospital. The Joint Commissions findings demonstrate how dedicated our physicians, clinical staff and associates are to providing the very best care for patients.
The Joint Commission accreditation and certification are nationally recognized as reflections of an organizations commitment to meeting certain performance standards.
Tags
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.
Heavy social media use linked to depression
August 31, 2026
U.S. News and World Report, Yahoo! News, MSN, USA Today and other national media highlight a new study by the University of Cincinnati and Northwestern University that found a correlation between heavy social media use and depression in adults.